ENST00000666466.2:n.1C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000666466.3(ENSG00000286391):​n.33C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0233 in 378,710 control chromosomes in the GnomAD database, including 522 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 144 hom., cov: 32)
Exomes 𝑓: 0.026 ( 378 hom. )

Consequence

ENSG00000286391
ENST00000666466.3 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.16

Publications

23 publications found
Variant links:
Genes affected
CHRNB2 (HGNC:1962): (cholinergic receptor nicotinic beta 2 subunit) Neuronal acetylcholine receptors are homo- or heteropentameric complexes composed of homologous alpha and beta subunits. They belong to a superfamily of ligand-gated ion channels which allow the flow of sodium and potassium across the plasma membrane in response to ligands such as acetylcholine and nicotine. This gene encodes one of several beta subunits. Mutations in this gene are associated with autosomal dominant nocturnal frontal lobe epilepsy. [provided by RefSeq, Jul 2008]
CHRNB2 Gene-Disease associations (from GenCC):
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nocturnal frontal lobe epilepsy 3
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 1-154567749-G-A is Benign according to our data. Variant chr1-154567749-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 673243.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.159 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000666466.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNB2
NM_000748.3
MANE Select
c.-296G>A
upstream_gene
N/ANP_000739.1P17787

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000286391
ENST00000659429.2
n.7C>T
non_coding_transcript_exon
Exon 1 of 2
ENSG00000286391
ENST00000664303.3
n.16C>T
non_coding_transcript_exon
Exon 1 of 2
ENSG00000286391
ENST00000666466.3
n.33C>T
non_coding_transcript_exon
Exon 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.0195
AC:
2957
AN:
151630
Hom.:
141
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00389
Gnomad AMI
AF:
0.00769
Gnomad AMR
AF:
0.0686
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.168
Gnomad SAS
AF:
0.00685
Gnomad FIN
AF:
0.00190
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0117
Gnomad OTH
AF:
0.0140
GnomAD4 exome
AF:
0.0257
AC:
5839
AN:
226970
Hom.:
378
Cov.:
0
AF XY:
0.0243
AC XY:
2820
AN XY:
115866
show subpopulations
African (AFR)
AF:
0.00238
AC:
13
AN:
5464
American (AMR)
AF:
0.0859
AC:
453
AN:
5276
Ashkenazi Jewish (ASJ)
AF:
0.000921
AC:
7
AN:
7604
East Asian (EAS)
AF:
0.197
AC:
3321
AN:
16832
South Asian (SAS)
AF:
0.00416
AC:
40
AN:
9622
European-Finnish (FIN)
AF:
0.00268
AC:
53
AN:
19784
Middle Eastern (MID)
AF:
0.000867
AC:
1
AN:
1154
European-Non Finnish (NFE)
AF:
0.0112
AC:
1637
AN:
146628
Other (OTH)
AF:
0.0215
AC:
314
AN:
14606
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
237
473
710
946
1183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0196
AC:
2967
AN:
151740
Hom.:
144
Cov.:
32
AF XY:
0.0208
AC XY:
1545
AN XY:
74154
show subpopulations
African (AFR)
AF:
0.00388
AC:
160
AN:
41220
American (AMR)
AF:
0.0691
AC:
1055
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.168
AC:
866
AN:
5158
South Asian (SAS)
AF:
0.00706
AC:
34
AN:
4814
European-Finnish (FIN)
AF:
0.00190
AC:
20
AN:
10554
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0117
AC:
794
AN:
67946
Other (OTH)
AF:
0.0138
AC:
29
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
146
293
439
586
732
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0184
Hom.:
172
Bravo
AF:
0.0255
Asia WGS
AF:
0.0520
AC:
181
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
13
DANN
Benign
0.81
PhyloP100
1.2
PromoterAI
0.20
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072658; hg19: chr1-154540225; API